The science does not support a fixed benchmark of 10,000 steps. Measurable health benefits begin at around 2,500-4,000 steps per day, the optimum for most adults is around 7,000-9,000 steps, with diminishing returns above that. Older adults reach the ceiling earlier, at around 6,000-8,000 steps.
The popular benchmark of 10,000 steps per day has no solid scientific basis as a universal threshold. Several large meta-analyses show that health benefits already begin at around 2,500 steps per day for cardiovascular mortality and around 3,867 steps per day for all-cause mortality. You therefore do not necessarily need to reach that 10,000 to achieve something (PMID 37555441, 35247352, 37676198).
Every additional 1,000 steps per day is associated with approximately a 15% lower risk of death (HR 0.85). For cardiovascular disease, every additional 500 steps is already associated with a 7% lower risk of dying from it. These are associations from a meta-analysis of 17 cohorts with nearly 227,000 participants, so large, robust figures, but not proof of cause and effect (PMID 37555441).
The greatest risk reduction for all-cause mortality is reached at around 8,763 steps per day; above that the effect levels off strongly. For cardiovascular disease, that inflection point is slightly lower, at around 7,126 steps per day. In people aged 60 and older, the plateau is already reached at 6,000 to 8,000 steps; younger adults benefit slightly longer from more steps (PMID 35247352, 37676198).
Good news for those who are not active every day: reaching 8,000 steps on just 1 or 2 days per week is already associated with nearly a 15% lower mortality risk compared with never reaching that threshold. Those who do so on 3 to 7 days per week achieve roughly a 16.5% reduction. The additional benefit beyond 3 days per week is therefore small. This suggests that regularity matters, but perfect daily consistency is not strictly necessary (PMID 36976556).
Besides the total number of steps, pace also matters: walking faster is independently associated with a lower mortality risk regardless of daily step count. In other words, a brisk walk is worth more than very slow strolling, even if you take the same number of steps (PMID 37676198, 35247352). All of these findings are associative in nature; they do not prove that taking more steps is directly the cause of a longer life.
All claims are based on large observational cohort studies and meta-analyses (up to 227,000 participants). These are associations, not randomised experiments, so reverse causality (sick people walk less) cannot be fully excluded, even though the studies partly adjust for this.